Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01954420 · ClinicalTrials.gov registry record · NA
A Brief Patient-Controlled Intervention for a Symptom Cluster in Advanced Cancer
A NA study of Cancer and Pain, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- NA
- Development phase
- 188
- Enrollment target
- 4
- Study locations
NCT01954420: Completed NA study of Cancer and Pain, sponsored by University of Wisconsin, Madison.
NCT01954420 is a NA study of Cancer and Pain that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 188 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (95% lower). The trial reports 4 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01954420, a NA study of Cancer and Pain, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- NA
- Development phase
- 188 participants
- Enrollment target
- 4
- Study locations
Study Summary
The purpose of the research is to test the efficacy of a patient-controlled cognitive-behavioral intervention for pain, fatigue, and sleep disturbance during cancer treatment, and to evaluate moderators and mediators of intervention effects. The intervention uses guided imagery, relaxation exercises, and nature sound recordings, self-administered via an MP3 player. The study will determine (1) if the intervention helps to control symptoms during chemotherapy, (2) if personal and clinical characteristics influence how well the intervention works, and (3) if the cognitive-behavioral strategies reduce markers of stress and inflammation found in blood and saliva.
Conditions Studied
Interventions
- OTHER Attention Control
- BEHAVIORAL Cognitive-Behavioral Intervention
Study Locations (4)
Wisconsin
- Mercy Health System - Janesville
- University of Wisconsin - Madison
- ProHealth Care - Waukesha
Illinois
- SwedishAmerican Regional Cancer Center - Rockford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 188 participants |
| Start Date | 2013-12 |
| Est. Completion | 2017-01-31 |
| Phase | NA |
What the finished NCT01954420 record still lists
NCT01954420 is an interventional study that assigns participants to a tested intervention. The registered 188 participants enrollment target is mid-sized for trials with a published cap, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (95% lower).
The record links to 4 conditions, with Cancer appearing as the primary indexed condition, and to 2 interventions - of which Attention Control is the first listed.
NCT01954420 reports a single indexed study location in Wisconsin, Illinois.
Frequently Asked Questions
What is clinical trial NCT01954420 about?
NCT01954420 is a clinical study titled "A Brief Patient-Controlled Intervention for a Symptom Cluster in Advanced Cancer". The purpose of the research is to test the efficacy of a patient-controlled cognitive-behavioral intervention for pain, fatigue, and sleep disturbance during cancer treatment, and to evaluate moderators and mediators of intervention effects. The intervention uses guided imagery, relaxation exercises...
What is the current status of trial NCT01954420?
This trial is currently completed. It is a NA study. The enrollment target is 188 participants. The study started on 2013-12. Estimated completion is 2017-01-31.
What conditions does trial NCT01954420 study?
This clinical trial studies the following conditions: Cancer, Pain, Fatigue, Sleep Disturbance.
What interventions are being tested in trial NCT01954420?
The interventions under investigation include: Attention Control (OTHER), Cognitive-Behavioral Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT01954420?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01954420 being conducted?
This trial has 4 study locations across Illinois, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01954420's enrollment target sits among peer trials
188 242nd of 615 higher than 371 of 615 other Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
BfedBwell Optimization Pilot
RECRUITING · NA
-
Legal Evaluation for Greater Access to Cancer Care (LEGAL-CARE)
RECRUITING · NA
-
Optimizing the AYA Survivors' Coping and Emotional Needs Toolkit
RECRUITING · NA
-
Comprehensive Connected Cancer Care (C4): Intervention Evaluation
RECRUITING · NA
-
Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03422198 · 188 participants · Phase 3
Short Course Vaginal Cuff Brachytherapy in Treating Participants With Stage I-II Endometrial Cancer
- NCT04469790 · 188 participants · NA
Effects of Multi-day Interruptions in Sitting on Type 2 Diabetes-relevant Outcomes in Children
- NCT04671667 · 188 participants · Phase 2
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
- NCT04853251 · 188 participants · Phase 4
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia